Yoon-La Choi (Yoon La Choi)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Brain Metastases

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of Korean medical science

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hyun Ae Jung, Jinyeong Lim, Yoon-La Choi, Jhingook Kim, Keunchil Park
Clinicopathologic and Molecular Subtyping of EGFR Mutation-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Hyun Ae Jung, Jinyeong Lim, Yoon-La Choi, Jhingook Kim, Keunchil Park
Clinicopathologic and Molecular Subtyping of EGFR Mutation-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Hyun Ae Jung, Jinyeong Lim, Yoon-La Choi, Jhingook Kim, Keunchil Park
Clinicopathologic and Molecular Subtyping of EGFR Mutation-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Junsu Choe, Areum Han, Sun-Hye Shin, Kyungjong Lee, Sang Won Um, Hojoong Kim, Tae Yeul Kim, Hee Jae Huh, Yoon-La Choi, Joungho Han, Byeong-Ho Jeong
Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses. Journal of Korean medical science 38 (47) (2023)
Hyun Ae Jung, Jinyeong Lim, Yoon-La Choi, Se-Hoon Lee, Je-Gun Joung, Yeong Jeong Jeon, Jae Won Choi, Sumin Shin, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Jae Ill Zo, Young Mog Shim, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Joungho Han, Woong-Yang Park, Jhingook Kim, Keunchil Park
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Hyun Ae Jung, Sehhoon Park, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Jong-Mu Sun
Continuation of Pembrolizumab with Additional Chemotherapy after Progression with PD-1/PD-L1 Inhibitor Monotherapy in Patients with Advanced NSCLC: A Randomized, Placebo-Controlled Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Sehhoon Park, Chan-Young Ock, Hyojin Kim, Sergio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong-Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung-Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung-Jue Bang, Yoon-La Choi, Tony S K Mok, Se-Hoon Lee
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Mercedes L Dalurzo, Alejandro Aviles, Fernando Augusto Soares, Ying-Yong Hou, Yuan Li, Anna Stroganova, Ayşim BÜge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi
Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets. OncoTargets and therapy 14 (2021)
Jung Ho Kim, Jeong Hoon Hong, Yoon-La Choi, Ji Ae Lee, Mi-Kyoung Seo, Mi-Sook Lee, Sung Bin An, Min Jung Sung, Nam-Yun Cho, Sung-Su Kim, Young Kee Shin, Sangwoo Kim, Gyeong Hoon Kang
NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions. The Journal of pathology 255 (4) (2021)
Byung Chan Lee, Hyun Jin Kim, Yoon-La Choi, Byung-Joon Jeon, Duk Hyun Sung
Radial neuropathy caused by intraneural leiomyoma: A case report. Medicine 99 (22) (2020)
Jongmin Sim, Hyunjin Kim, Jiyeon Hyeon, Yoon-La Choi, Joungho Han
Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors. Journal of Korean medical science 33 (15) (2018)